Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.

Huber V, Vallacchi V, Fleming V, Hu X, Cova A, Dugo M, Shahaj E, Sulsenti R, Vergani E, Filipazzi P, De Laurentiis A, Lalli L, Di Guardo L, Patuzzo R, Vergani B, Casiraghi E, Cossa M, Gualeni A, Bollati V, Arienti F, De Braud F, Mariani L, Villa A, Altevogt P, Umansky V, Rodolfo M, Rivoltini L.

J Clin Invest. 2018 Nov 5. pii: 98060. doi: 10.1172/JCI98060. [Epub ahead of print]

2.

Antioxidant and antimicrobial properties of Casteanea sativa Miller chestnut honey produced on Mount Etna (Sicily).

Ronsisvalle S, Lissandrello E, Fuochi V, Petronio Petronio G, Straquadanio C, Crascì L, Panico A, Milito M, Cova AM, Tempera G, Furneri PM.

Nat Prod Res. 2017 Dec 13:1-8. doi: 10.1080/14786419.2017.1413568. [Epub ahead of print]

PMID:
29232982
3.

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.

Bossi P, Bergamini C, Miceli R, Cova A, Orlandi E, Resteghini C, Locati L, Alfieri S, Imbimbo M, Granata R, Mariani L, Iacovelli NA, Huber V, Cavallo A, Licitra L, Rivoltini L.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):959-966. doi: 10.1016/j.ijrobp.2016.08.047. Epub 2016 Sep 6.

PMID:
27745982
4.

Caspase-3 activation in human melanoma A375 cell line by a novel selective sigma-2 agonist.

Ronsisvalle S, Arico G, Cova AM, Blanco P, Amata E, Pappalardo M, Pasquinucci L, Spadaro A, Ronsisvalle N.

Pharmazie. 2016 Mar;71(3):146-51.

PMID:
27183709
5.

Effect of sugar addition on glass transition temperatures of cassava starch with low to intermediate moisture contents.

Figueroa Y, Guevara M, Pérez A, Cova A, Sandoval AJ, Müller AJ.

Carbohydr Polym. 2016 Aug 1;146:231-7. doi: 10.1016/j.carbpol.2016.03.054. Epub 2016 Mar 22.

PMID:
27112870
6.

TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site.

Rivoltini L, Chiodoni C, Squarcina P, Tortoreto M, Villa A, Vergani B, Bürdek M, Botti L, Arioli I, Cova A, Mauri G, Vergani E, Bianchi B, Della Mina P, Cantone L, Bollati V, Zaffaroni N, Gianni AM, Colombo MP, Huber V.

Clin Cancer Res. 2016 Jul 15;22(14):3499-512. doi: 10.1158/1078-0432.CCR-15-2170. Epub 2016 Mar 4.

7.

Parasites in the mangrove oyster Crassostrea rhizophorae cultivated in the estuary of the Graciosa River in Taperoá, Bahia.

Cova AW, Serafim Júnior M, Boehs G, Souza JM.

Rev Bras Parasitol Vet. 2015 Jan-Mar;24(1):21-7. doi: 10.1590/S1984-29612015012.

8.

DSC investigation of the effect of the new sigma ligand PPCC on DMPC lipid membrane.

Sarpietro MG, Accolla ML, Cova A, Prezzavento O, Castelli F, Ronsisvalle S.

Int J Pharm. 2014 Jul 20;469(1):88-93. doi: 10.1016/j.ijpharm.2014.04.052. Epub 2014 Apr 23.

PMID:
24768402
9.

Glass transitions and physical aging of cassava starch - corn oil blends.

Pérez A, Sandoval AJ, Cova A, Müller AJ.

Carbohydr Polym. 2014 May 25;105:244-52. doi: 10.1016/j.carbpol.2014.01.032. Epub 2014 Jan 31.

PMID:
24708977
10.

HNF4α contributes to glucose formation in aged rat hepatocytes.

Park EY, Lee CH, Lee EK, Kim JH, Cova A, Lee SK, Cho SC, Kwak CS, Song KY, Park SC, Jun HS, Kim KT.

Exp Gerontol. 2013 Dec;48(12):1518-25. doi: 10.1016/j.exger.2013.10.011. Epub 2013 Oct 29.

PMID:
24177414
11.

Anti-plasticization of cassava starch by complexing fatty acids.

Luk E, Sandoval AJ, Cova A, Müller AJ.

Carbohydr Polym. 2013 Oct 15;98(1):659-64. doi: 10.1016/j.carbpol.2013.06.058. Epub 2013 Jun 28.

PMID:
23987396
12.

Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response.

Camisaschi C, Filipazzi P, Tazzari M, Casati C, Beretta V, Pilla L, Patuzzo R, Maurichi A, Cova A, Maio M, Chiarion-Sileni V, Tragni G, Santinami M, Vergani B, Villa A, Berti E, Umansky L, Beckhove P, Umansky V, Parmiani G, Rivoltini L, Castelli C.

Cancer Immunol Immunother. 2013 May;62(5):897-908. doi: 10.1007/s00262-013-1397-7. Epub 2013 Apr 16.

13.

Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides.

Filipazzi P, Pilla L, Mariani L, Patuzzo R, Castelli C, Camisaschi C, Maurichi A, Cova A, Rigamonti G, Giardino F, Di Florio A, Asioli M, Frati P, Sovena G, Squarcina P, Maio M, Danielli R, Chiarion-Sileni V, Villa A, Lombardo C, Tragni G, Santinami M, Parmiani G, Rivoltini L.

Clin Cancer Res. 2012 Dec 1;18(23):6485-96. doi: 10.1158/1078-0432.CCR-12-1516. Epub 2012 Oct 2.

14.

Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

Calcinotto A, Filipazzi P, Grioni M, Iero M, De Milito A, Ricupito A, Cova A, Canese R, Jachetti E, Rossetti M, Huber V, Parmiani G, Generoso L, Santinami M, Borghi M, Fais S, Bellone M, Rivoltini L.

Cancer Res. 2012 Jun 1;72(11):2746-56. doi: 10.1158/0008-5472.CAN-11-1272. Epub 2012 May 16.

15.

Effect of UVA-activated riboflavin on dentin bonding.

Cova A, Breschi L, Nato F, Ruggeri A Jr, Carrilho M, Tjäderhane L, Prati C, Di Lenarda R, Tay FR, Pashley DH, Mazzoni A.

J Dent Res. 2011 Dec;90(12):1439-45. doi: 10.1177/0022034511423397. Epub 2011 Sep 22.

16.

Alterations of epinephrine-induced gluconeogenesis in aging.

Kim K, Cho SC, Cova A, Jang IS, Park SC.

Exp Mol Med. 2009 May 31;41(5):334-40. doi: 10.3858/emm.2009.41.5.037.

17.

Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.

Martayan A, Sibilio L, Tremante E, Lo Monaco E, Mulder A, Fruci D, Cova A, Rivoltini L, Giacomini P.

J Immunol. 2009 Mar 15;182(6):3609-17. doi: 10.4049/jimmunol.0802316.

18.

Two different techniques in the rehabilitation treatment of low back pain: a randomized controlled trial.

Donzelli S, Di Domenica E, Cova AM, Galletti R, Giunta N.

Eura Medicophys. 2006 Sep;42(3):205-10.

19.

Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

Di Pucchio T, Pilla L, Capone I, Ferrantini M, Montefiore E, Urbani F, Patuzzo R, Pennacchioli E, Santinami M, Cova A, Sovena G, Arienti F, Lombardo C, Lombardi A, Caporaso P, D'Atri S, Marchetti P, Bonmassar E, Parmiani G, Belardelli F, Rivoltini L.

Cancer Res. 2006 May 1;66(9):4943-51.

20.

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients.

Pilla L, Patuzzo R, Rivoltini L, Maio M, Pennacchioli E, Lamaj E, Maurichi A, Massarut S, Marchianò A, Santantonio C, Tosi D, Arienti F, Cova A, Sovena G, Piris A, Nonaka D, Bersani I, Di Florio A, Luigi M, Srivastava PK, Hoos A, Santinami M, Parmiani G.

Cancer Immunol Immunother. 2006 Aug;55(8):958-68. Epub 2005 Oct 8.

PMID:
16215718
21.

Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.

Tosi D, Valenti R, Cova A, Sovena G, Huber V, Pilla L, Arienti F, Belardelli F, Parmiani G, Rivoltini L.

J Immunol. 2004 May 1;172(9):5363-70.

22.

Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.

Rivoltini L, Castelli C, Carrabba M, Mazzaferro V, Pilla L, Huber V, Coppa J, Gallino G, Scheibenbogen C, Squarcina P, Cova A, Camerini R, Lewis JJ, Srivastava PK, Parmiani G.

J Immunol. 2003 Oct 1;171(7):3467-74.

23.

Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.

Carrabba MG, Castelli C, Maeurer MJ, Squarcina P, Cova A, Pilla L, Renkvist N, Parmiani G, Rivoltini L.

Cancer Res. 2003 Apr 1;63(7):1560-7.

24.

Adoptive transfer of an anti-MART-1(27-35)-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID mice.

Lozupone F, Rivoltini L, Luciani F, Venditti M, Lugini L, Cova A, Squarcina P, Parmiani G, Belardelli F, Fais S.

Eur J Immunol. 2003 Feb;33(2):556-66.

25.

Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.

Belli F, Testori A, Rivoltini L, Maio M, Andreola G, Sertoli MR, Gallino G, Piris A, Cattelan A, Lazzari I, Carrabba M, Scita G, Santantonio C, Pilla L, Tragni G, Lombardo C, Arienti F, Marchianò A, Queirolo P, Bertolini F, Cova A, Lamaj E, Ascani L, Camerini R, Corsi M, Cascinelli N, Lewis JJ, Srivastava P, Parmiani G.

J Clin Oncol. 2002 Oct 15;20(20):4169-80. Erratum in: J Clin Oncol 2002 Dec 1;20(23):4610.

PMID:
12377960
26.

In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells: evidence of programmed cell death after muscle cell transplantation.

Del Bo R, Torrente Y, Corti S, D'Angelo MG, Comi GP, Fagiolari G, Salani S, Cova A, Pisati F, Moggio M, Ausenda C, Scarlato G, Bresolin N.

Cell Transplant. 2001 Mar-Apr;10(2):209-21.

PMID:
11332636
27.

[Women and the welfare state: France from 1892 to 1939].

Cova A, Piretti S, Neri Serneri S.

Contemporanea. 1999;2(2):205-20. Italian. No abstract available.

PMID:
20120559
28.

A bilateral model integrating vergence and the vestibulo-ocular reflex.

Cova AC, Galiana HL.

Exp Brain Res. 1996;107(3):435-52.

PMID:
8821384
29.
31.

Analytical profile of denzimol hydrochloride new anticonvulsant drug.

Tajana A, Sibilia C, Cappelletti R, Cova A, Nardi D.

Boll Chim Farm. 1986 Jan;125(1):7-20. No abstract available.

PMID:
3730178
32.

Physico-chemical, structural and analytical studies on fenticonazole, a new drug with antimycotic properties.

Tajana A, Sibilia C, Cappelletti R, Cova A, Nardi D.

Arzneimittelforschung. 1981;31(12):2127-33. No abstract available.

PMID:
7199312
33.

Is there a physiological intravascular coagulation in obstetrical cases?

Arocha-Piñango CL, Linares J, Cova A, Martínez P.

Acta Obstet Gynecol Scand. 1979;58(1):27-30.

PMID:
419951
34.

[Urinary excretion of flavoxate administered in combination with metamizole].

Scanni A, Tomirotti M, Biraghi M, Cova A.

Boll Chim Farm. 1977 Oct;116(10):584-8. Italian. No abstract available.

PMID:
343796
35.

[Blood concentration and urinary elimination of dimefline after single oral administration in man].

Scanni A, Biraghi M, Tomirotti M, Cova A.

Boll Chim Farm. 1977 Jun;116(6):353-7. Italian. No abstract available.

PMID:
889638
36.

[Urinary kinetics and tolerance of oral flavoxate in man].

Benvenuti C, Cova A, Simonazzi I.

Farmaco Prat. 1977 Feb;32(2):99-107. Italian. No abstract available.

PMID:
849779
37.

Pharmacokinetics of Flavoxate in man.

Bertoli M, Conti F, Conti M, Cova A, Setnikar I.

Pharmacol Res Commun. 1976 Aug;8(4):417-28. No abstract available.

PMID:
1026965
38.

Intravascular coagulation in obstetrics: Serial dilution protamine sulfate test throughout labor.

Arocha Piñango CL, Linares J, Cova A, Martínez P, Montilla G, Rodríguez S.

Am J Obstet Gynecol. 1976 Jan 1;124(1):18-20.

PMID:
1244742
39.
40.

Pharmacokinetics of flavoxate in rats.

Setnikar I, Cova A, Magistretti MJ.

Arzneimittelforschung. 1975;25(12):1916-20.

PMID:
1243663
41.

Gas chromatographic separation of "pseudostilbestrol" from cis- and trans-diethylstilbestrol.

Fontani F, Cova A.

Farmaco Prat. 1972 Jun;27(6):334-7. No abstract available.

PMID:
5032931
42.

[Lipids from bovine caseous necrotic substance. II. Granuloma inducing activity of lipids from bovine caseous necrotic substance].

COVA AA, COVA N.

G Ital Della Tuberc. 1956 Mar-Apr;10(2):117-26. Italian. No abstract available.

PMID:
13331187

Supplemental Content

Support Center